Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 5/20 | 0.44 |
| ▸ | TAS1R1 | Q7RTX1 | 5/20 | 0.44 |
| ▸ | TAS1R2 | Q8TE23 | 5/20 | 0.44 |
| ▸ | PNMT | P11086 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 3/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | CCR4 | P51679 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17356809 | 0.87 | PNMT (0.46) | TAS1R3TAS1R1TAS1R2PNMTCHRNB2 | |
| SCHEMBL17356805 | 0.86 | PNMT (0.43) | TAS1R3TAS1R1TAS1R2PNMTCHRNB2 | |
| SCHEMBL17356808 | 0.80 | PNMT (0.53) | TAS1R3TAS1R1TAS1R2PNMTCHRNB2 | |
| SCHEMBL17356802 | 0.79 | PNMT (0.38) | TAS1R3TAS1R1TAS1R2PNMTCHRNB2 | |
| SCHEMBL17356803 | 0.79 | PNMT (0.43) | TAS1R3TAS1R1TAS1R2PNMTCHRNB2 | |
| SCHEMBL17356798 | 0.76 | GAA (0.51) | TAS1R3TAS1R1TAS1R2PNMTGAA | |
| SCHEMBL17356791 | 0.73 | ABCB1 (0.42) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL17356804 | 0.72 | HTR2C (0.47) | TAS1R3TAS1R1TAS1R2PNMTGAA | |
| SCHEMBL27881934 | 0.72 | ALDH1A1 (0.43) | TAS1R3TAS1R1TAS1R2TDP1MAP3K14 | |
| SCHEMBL8125269 | 0.69 | HTR2C (0.46) | TAS1R3TAS1R1TAS1R2HTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170313792-A1 | METHOD FOR PRODUCING POLAR GROUP-CONTAINING OLEFIN POLYMER | THE UNIVERSITY OF TOKYO (JP) | 2017-11-02 | — | — | US | disclosed |
| US-9499644-B2 | Production method of polar group-containing olefin polymers | SHOWA DENKO K.K. (JP) | 2016-11-22 | — | — | US | disclosed |
| US-20150368376-A1 | PRODUCTION METHOD OF POLAR GROUP-CONTAINING OLEFIN POLYMERS | SHOWA DENKO K.K. (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368376-A1 | PRODUCTION METHOD OF POLAR GROUP-CONTAINING OLEFIN POLYMERS | OR10J3, OPRM1, ORC3 | TAS1R3 1857/4885TAS1R1 2747/4885TAS1R2 2783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.